Cite Filings / ASPE / 0001193125-26-454047

Feed Companies Filings Check

Sign in

SCHEDULE 13D

Beneficial Ownership Report

Aspen Neuroscience, Inc. Filed 2026-11-09 Acc 0001193125-26-454047

Documents 1

SCHEDULE 13D Beneficial Ownership Report , xslSCHEDULE_13D_X02/primary_doc.xml

Around this filing

2026-11-09 SCHEDULE 13G Statement of Beneficial Ownership
2026-11-09 SCHEDULE 13D Beneficial Ownership Report
2026-11-09 4 Executive Chair acquired 321,672 shares (grant or award)
2026-11-06 SCHEDULE 13G Statement of Beneficial Ownership
2026-11-06 SCHEDULE 13D Beneficial Ownership Report
2026-11-06 SCHEDULE 13G Statement of Beneficial Ownership
2026-11-04 4 Director bought 1,000,000 shares at $15.00 ($15,000,000)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…